BioSpace News Archive

Cantex Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a “Study May Proceed” letter for the Miami Cancer Institute’s investigator initiated clinical trial to assess the safety and effectiveness of azeliragon combined with stereotactic radiosurgery in patients with brain metastases.

Rallybio Corporation (Nasdaq: RLYB) today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided an update on recent program and corporate developments.

Resolution Medical, an end-to-end contract development and manufacturing organization focused on complex and rapidly growing medical technology segments, announced the appointment of Peter Herman as Chief Executive Officer.

Edgewise Therapeutics, Inc. announced today the appointment of Jonathan C. Fox, M.D., Ph.D., FACC, to its Board of Directors.

Alto Neuroscience today announced that founder and chief executive officer, Amit Etkin, M.D., Ph.D., will present at the Oppenheimer 33rd Annual Healthcare Conference taking place virtually.

Lineage Cell Therapeutics, Inc. today announced that results from imaging analyses of structural changes in addition to visual data from a Phase 1/2a clinical study of RG6501.

Quanterix Corporation today announced financial results for the fourth quarter and twelve months ended December 31, 2022.

Surgalign Holdings, Inc. provided updates on its previously announced restructuring plan.

AIM ImmunoTech Inc. issued a letter to stockholders highlighting key accomplishments in 2022 and outlining corporate objectives for 2023.

IRADIMED CORPORATION today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Roth Conference in Laguna Niguel, CA.